NovaBridge Biosciences Increase (Decrease) in Deferred Liabilities
NovaBridge Biosciences (NBP) reported Increase (Decrease) in Deferred Liabilities of -CNY 7.51 million for the 12-month period ending 2021-12-31, per its 20-F filed 2024-04-30.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredLiabilities · last filed 2024-04-30
- NovaBridge Biosciences increase (decrease) in deferred liabilities for the quarter ending 2020-12-31 was -129.00K CNY.
- NovaBridge Biosciences increase (decrease) in deferred liabilities for the quarter ending 2019-12-31 was 0.00 CNY.
CNY
| Period end | Increase (Decrease) in Deferred Liabilities 3 month | Increase (Decrease) in Deferred Liabilities 6 month | Increase (Decrease) in Deferred Liabilities 9 month | Increase (Decrease) in Deferred Liabilities 12 month |
|---|---|---|---|---|
| 2021-12-31 | -7.51M CNY 20-F · filed 2024-04-30 | |||
| 2021-06-30 | -2.95M CNY 6-K · filed 2022-11-10 | |||
| 2020-12-31 | -129.00K CNY derived: 20-F 12 month − 6-K 9 month · filed 2023-05-01 | 3.59M CNY 20-F · filed 2023-05-01 | ||
| 2020-09-30 | 3.72M CNY 6-K · filed 2021-02-05 | |||
| 2019-12-31 | 0.00 CNY derived: 20-F 12 month − 6-K 9 month · filed 2022-04-29 | 1.42M CNY 20-F · filed 2022-04-29 | ||
| 2019-09-30 | 1.42M CNY 6-K · filed 2021-02-05 | |||
| 2018-12-31 | 2.50M CNY 20-F · filed 2021-04-28 |
USD
| Period end | Increase (Decrease) in Deferred Liabilities 3 month | Increase (Decrease) in Deferred Liabilities 9 month | Increase (Decrease) in Deferred Liabilities 12 month |
|---|---|---|---|
| 2021-12-31 | -$1.18M 20-F · filed 2022-04-29 | ||
| 2020-12-31 | $2.00K derived: 20-F 12 month − 6-K 9 month · filed 2021-04-28 | $550.00K 20-F · filed 2021-04-28 | |
| 2020-09-30 | $548.00K 6-K · filed 2021-02-05 | ||
| 2019-12-31 | $204.00K 20-F · filed 2020-04-29 |